These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 3161586)
1. Protection from guanethidine-induced neuronal destruction by nerve growth factor: effect of NGF on immune function. Manning PT; Russell JH; Simmons B; Johnson EM Brain Res; 1985 Aug; 340(1):61-9. PubMed ID: 3161586 [TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive agents prevent guanethidine-induced destruction of rat sympathetic neurons. Manning PT; Russell JH; Johnson EM Brain Res; 1982 Jun; 241(1):131-43. PubMed ID: 6125238 [TBL] [Abstract][Full Text] [Related]
3. The effects of drug which destroy the sympathetic nervous system on the retrograde transport of nerve growth factor. Johnson EM; Macia RA; Andres RY; Bradshaw RA Brain Res; 1979 Aug; 171(3):461-72. PubMed ID: 89888 [TBL] [Abstract][Full Text] [Related]
5. Species and structural specificity of the lipopigment accumulation and neuronal destruction induced by N-(2-guanidinoethyl)-4-methyl-1,2,5,6-tetrahydropyridine (guanacline). Johnson EM; Palmatier MA; Rydel RE; Manning PT Brain Res; 1986 Sep; 383(1-2):100-9. PubMed ID: 3768685 [TBL] [Abstract][Full Text] [Related]
6. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure. Hiserodt JC J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707 [TBL] [Abstract][Full Text] [Related]
7. Effect of immunosuppressive agents on the guanethidine-induced sympathectomy in athymic and euthymic rats. Hougen HP; Thygesen P; Christensen HB; Rygaard J; Svendsen O; Juul P Int J Immunopharmacol; 1992 Aug; 14(6):1113-23. PubMed ID: 1385339 [TBL] [Abstract][Full Text] [Related]
8. Unique resistance to guanethidine-induced chemical sympathectomy of spontaneously hypertensive rats: a resistance overcome by treatment with antibody to nerve growth factor. Johnson EM; Macia RA Circ Res; 1979 Aug; 45(2):243-9. PubMed ID: 36237 [TBL] [Abstract][Full Text] [Related]
9. Guanethidine-mediated destruction of ovarian sympathetic nerves disrupts ovarian development and function in rats. Lara HE; McDonald JK; Ahmed CE; Ojeda SR Endocrinology; 1990 Nov; 127(5):2199-209. PubMed ID: 1977580 [TBL] [Abstract][Full Text] [Related]
10. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro. Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374 [TBL] [Abstract][Full Text] [Related]
11. MHC-specific cytotoxic T lymphocyte killing of dissociated sympathetic neuronal cultures. Manning PT; Johnson EM; Wilcox CL; Palmatier MA; Russell JH Am J Pathol; 1987 Sep; 128(3):395-409. PubMed ID: 3498368 [TBL] [Abstract][Full Text] [Related]
12. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones. Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760 [TBL] [Abstract][Full Text] [Related]
13. Retrograde axonal transport in rat ileal mesenteric nerves. Characterization using intravenously administered 125I-nerve growth factor and effect of chemical sympathectomy. Schmidt RE; Yip HK Diabetes; 1985 Dec; 34(12):1222-9. PubMed ID: 2415413 [TBL] [Abstract][Full Text] [Related]
14. Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin. Seki N; Brooks AD; Carter CR; Back TC; Parsoneault EM; Smyth MJ; Wiltrout RH; Sayers TJ J Immunol; 2002 Apr; 168(7):3484-92. PubMed ID: 11907109 [TBL] [Abstract][Full Text] [Related]
15. Recognition and response to alloantigens in vivo. I. Negative and positive selection of MLR reactivity in murine peripheral blood lymphocytes to major histocompatibility complex and Mls antigens. Ryan JJ; Ahmed A; Kind PD; Thompson CB; Berning AK; Sell KW J Immunol; 1984 Aug; 133(2):606-15. PubMed ID: 6234352 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of tumor-specific cytotoxic T-lymphocyte responses by transforming growth factor beta 1. Inge TH; Hoover SK; Susskind BM; Barrett SK; Bear HD Cancer Res; 1992 Mar; 52(6):1386-92. PubMed ID: 1531782 [TBL] [Abstract][Full Text] [Related]
17. Mouse lymphoblasts lose their immunogenicity and susceptibility to specific cytotoxic T lymphocyte lysis during maintenance in culture. Leshem B; Brass D Immunology; 1998 Nov; 95(3):409-18. PubMed ID: 9824505 [TBL] [Abstract][Full Text] [Related]
18. Studies on the induction and expression of T cell-mediated immunity. XIV. Antigen-nonspecific oxidation-dependent cellular cytotoxicity (ODCC) mediated by sodium periodate oxidation of cytotoxic T lymphocytes. Fan J; Bonavida B J Immunol; 1983 Sep; 131(3):1426-32. PubMed ID: 6193189 [TBL] [Abstract][Full Text] [Related]
19. Regulation of in vitro cytotoxic T lymphocyte generation. I. Evidence that killer cell precursors differentiate to effector cells in two steps. Schwartz A; Sutton SL; Gershon RK J Exp Med; 1982 Mar; 155(3):783-96. PubMed ID: 6120990 [TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of a human T cell hybrid factor on both cell growth and mixed lymphocyte reactivity. Correlation with class II molecule expression. Trucco M; Shaw S; Korngold R J Clin Invest; 1985 Sep; 76(3):1032-41. PubMed ID: 2931451 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]